Satish Mandlik – författare
Visar alla böcker från författaren . Handla med fri frakt och snabb leverans.
3 produkter
3 produkter
Häftad, Engelska, 2026
1 778 kr
Skickas inom 10-15 vardagar
Exploring Nanocarriers in Breast Cancer Management comprehensively delves into the realm of nanocarrier systems, which have shown immense potential in the management of breast cancer. The scope of this book encompasses a thorough exploration of various nanocarrier systems, including, amongst others, liposomes, niosomes, and microneedles. It highlights recent advancements in these systems and their promising results in breast cancer treatment. Additionally, the book addresses the crucial aspects of toxicity and regulatory considerations associated with nanocarriers. It aims to provide a foundational understanding of nanocarriers, their unique features, and their significant role in breast cancer management.As breast cancer remains one of the most prevalent forms of cancer today, with no definitive cure currently available, this book is an essential resource for researchers, healthcare professionals, and anyone interested in cutting-edge developments in breast cancer treatment.Explores various, promising nanocarriers and their roles in breast cancer management, providing a comprehensive understanding of their applicationsExamines the regulatory aspects and toxicities associated with different nanocarrier systems, offering valuable insights for researchers and healthcare professionalsHighlights recent advancements in nanocarrier technology, showcasing the latest developments and their potential impact on breast cancer treatment
E-bok
Engelska, 20262 456 kr
Läs direkt efter köp
Exploring Nanocarriers in Breast Cancer Management comprehensively delves into the realm of nanocarrier systems, which have shown immense potential in the management of breast cancer. The scope of this book encompasses a thorough exploration of various nanocarrier systems, including, amongst others, liposomes, niosomes, and microneedles. It highlights recent advancements in these systems and their promising results in breast cancer treatment. Additionally, the book addresses the crucial aspects of toxicity and regulatory considerations associated with nanocarriers. It aims to provide a foundational understanding of nanocarriers, their unique features, and their significant role in breast cancer management.As breast cancer remains one of the most prevalent forms of cancer today, with no definitive cure currently available, this book is an essential resource for researchers, healthcare professionals, and anyone interested in cutting-edge developments in breast cancer treatment. - Explores various, promising nanocarriers and their roles in breast cancer management, providing a comprehensive understanding of their applications- Examines the regulatory aspects and toxicities associated with different nanocarrier systems, offering valuable insights for researchers and healthcare professionals- Highlights recent advancements in nanocarrier technology, showcasing the latest developments and their potential impact on breast cancer treatment
Häftad, Engelska, 2026
2 034 kr
Kommande
Covers detailed disease mechanisms and the full spectrum of immune cell biology, through to advanced clinical applications The book highlights the latest advances in immunotherapy, including cell-based and next-generation treatments. Immunity and Immunotherapy in Inflammatory Bowel Diseases (IBD): Mechanisms and Innovations bridges laboratory research with clinical practice, addressing diagnostics, biomarkers and real-world patient care. It tackles current challenges in IBD, such as therapy resistance, the integration of AI and multi-omic approaches. What sets this book apart is its extensive, up-to-date coverage of all immunotherapeutic strategies, such as monoclonal antibodies, cytokine inhibitors, JAK inhibitors, cell-based therapies, and novel targets such as CAR-T cells and immune checkpoint modulators. It also addresses emerging technologies, personalized medicine, resistance mechanisms, safety, and the gut microbiome, providing a holistic view of current and future directions in IBD immunotherapy.Written and edited by experts in the field, ‘Immunity and Immunotherapy in Inflammatory Bowel Diseases (IBD): Mechanisms and Innovations’ provides comprehensive insights into the immunopathogenesis of IBDOffers detailed descriptions of both established and emerging immunotherapiesProvides a single resource for crucial information on IBD immunity and immunotherapy, from the molecular factors involved to treatment prospects and future directionsProvides an extensive, up-to-date coverage of all immunotherapeutic strategies, such as monoclonal antibodies, cytokine inhibitors, JAK inhibitors, cell-based therapies, together with novel targets such as CAR-T cells and immune checkpoint modulators